Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
We break down Which Index Funds To Buy For Retirement 2024, focusing on costs, diversification, and track records to help you decide.
24,904 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A recent insider sale of 5,595 Hilton Grand Vacations shares has investors asking what it means for the stock. This g...
Oklo is combining AI with nuclear reactor design to shorten development timelines and improve safety. This article br...
Looking to turn a $1,000 into lasting passive income? This guide shows how dividend stocks yielding over 8.5% can fit...
OpenAI is quietly pitching its products to U.S. military and national security clients, a move that could reshape fun...
Taiwan enacted a comprehensive stablecoin framework on June 30, 2025, mandating full reserves, domestic custody, and ...
Microsoft leads a renewed sector rotation as AI momentum and stable cloud revenue lift its outlook, while Intel stumb...
Bitcoin eyes a pivotal breakout above 72K as bulls try to turn a fragile recovery into a sustained move. A breach of ...
Over the July Fourth weekend, the seventh film animated franchise led the box office, edging out Toy Story 5 as famil...
On July 1, Meta Platforms lit up the market with a 9% jump that pushed the stock toward $612.91. The move followed re...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
Starboard Value’s effort at Dynatrace tests whether the observability software maker can turn around on its own or be...